Biodexa Pharmaceuticals PLC (listed on NASDAQ: BDRX) is a clinical stage biopharmaceutical company developing a pipeline of products aimed at primary and metastatic cancers of the brain.
Biodexa Pharmaceuticals is covered by the following research analysts:
Analyst: Jyoti Prakash
Edison Investment Research Limited
+44 (0) 20 3077 5700
Please note that any opinions, estimates or forecasts made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Biodexa Pharmaceuticals or its management. Requests for copies of analyst reports should be directed at the respective analyst and institution.